Afatinib
- PDF / 168,855 Bytes
- 1 Pages / 595.245 x 841.846 pts (A4) Page_size
- 85 Downloads / 176 Views
1 S
Diarrhoea and nail toxicity: 2 case reports In a retrospective study conducted between 2012 and 2017 involving 67 patients, two patients [ages and sexes not stated] were described of whom, one patient developed grade 3 diarrhoea and another patient developed grade 3 nail toxicity following administration of oral afatinib 40mg for non-small-cell lung cancer (NSCLC) [durations of treatment to reaction onset and outcomes not stated]. Moran T, et al. Clinical Activity of Afatinib in Patients With Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Spanish Retrospective Multicenter 803507203 Study. Clinical Lung Cancer 21: 428-436, No. 5, Sep 2020. Available from: URL: http://doi.org/10.1016/j.cllc.2020.04.011
0114-9954/20/1826-0001/$14.95 Adis © 2020 Springer Nature Switzerland AG. All rights reserved
Reactions 17 Oct 2020 No. 1826
Data Loading...
